Navigation Links
Engineering technology pinpoints earliest signs of animal life
Date:2/5/2009

Scientists using revolutionary new technology developed at The University of Nottingham have recorded the earliest evidence of animal life so far.

Using a scientific technique known as Hydropyrolysis (using hydrogen gas at high pressure) they have been able to date chemical fossils discovered in sedimentary rocks in Oman. The high-precision technique has shown that these fossil steroids, remnants of a type of sponge known as Demosponges, are between 635 and 750 million years old. They date back to around the time of the Marinoan glaciation, the last of the huge ice ages at the end of the Neoproterozoic era.

The research, published in Nature on February 5 2009, suggests that the shallow waters in some late Cryogenian ocean basins contained dissolved oxygen in concentrations sufficient to support simple multicellular animals at least 100 million years before the rapid diversification of bilaterians early animals with a bilateral symmetry during an interval known as the Cambrian explosion by palaeontologists.

Colin Snape, Professor of Chemical Technology and Chemical Engineering, in the School of Chemical and Environmental Engineering, said: "This landmark study on marine ecosystems was made possible by the unique capability of hydropyrolysis to release key biomarkers from ancient rocks with minimal structural alteration."

Hydropyrolysis also known as HyPy was developed into a commercial system through collaboration with Engineering & Quality Systems and reactor engineering specialist Strata Technology. It was originally designed to liquefy large quantities of coal and strip down complex mixtures of organic chemicals down to their pure carbon skeletons. The technology, which recently won The 2008 Engineer Business Support and Universities Award, also has applications for detecting steroid abuse and cleaning up charcoal samples for radiocarbon dating.

Using biomarker analysis, the discovery, by an international research team from America, Australia and the UK, represents the oldest evidence for animals in the fossil record, and the first evidence for animals predating the termination of the Marinoan glaciations, the second of the two major glacial episodes of the Neoproterozoic which terminated 635 million years ago.

Dr Gordon Love, from the Department of Earth Sciences at the University of California, the principal author on the study said: "By establishing a robust stratigraphic and temporal framework for the Neoproterozoic-Cambrian South Oman Salt Basin strata and by employing state-of-the-art analytical techniques for biomarker recovery and analysis then we have unearthed the first fossil evidence for Cryogenian animals from the detection of anomalously high amount of distinctive steroids produced by sponges. We believe that we are converging on the correct date for the divergence of complex multicellular animal life, between 635 and 750 million years ago. It appears that the climatic shock of the two major glacial episodes of the Neoproterozoic caused a major reorganisation of marine ecosystems including the evolution of animal feeders living on the seafloor. In future, we and others will be screening other sedimentary rocks for animal steroids around and before the first glaciation event, the Sturtian, but so far no convincing signals have been detected prior to the Sturtian glaciation."


'/>"/>

Contact: Lindsay Brooke
lindsay.brooke@nottingham.ac.uk
44-011-595-15751
University of Nottingham
Source:Eurekalert

Related biology news :

1. Advancement in tissue engineering promotes oral wound healing
2. Stevens receives $25,000 grant from the Engineering Information Foundation
3. Developer of advanced computing memory, father of biochemical engineering, and innovative engineering educators win highest engineering honors of 2009
4. NTU undergrad is first Singapore champion of an internationally acclaimed engineering competition
5. Engineering algae to make fuel instead of sugar
6. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
7. Stanley to Continue Biometrics In-Service Engineering Support for U.S. Army
8. MIT: Mending broken hearts with tissue engineering
9. NJIT professor finds engineering technique to identify disease-causing genes
10. University success at national engineering awards
11. US Senate confirms Clemson University engineering Dean Esin Gulari to National Science Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology: